Showing results (261-270 of 390) with videos related to
Sort By:
Pageof 39
Cancers|November 12, 2013
The Expression of MTUS1/ATIP and Its Major Isoforms, ATIP1 and ATIP3, in Human Prostate CancerSimon N S Louis, Laurie T C Chow, Naghmeh Varghayee, et al.European Journal of Medicinal Chemistry|July 9, 2004
Site-directed mutagenesis of the rat beta1-adrenoceptor. Involvement of Tyr356 (7.43) in (+/-)cyanopindolol but not (+/-)[125Iodo]cyanopindolol bindingLinda A Rezmann-Vitti, Simon N S Louis, Tracy L Nero, et al.Rheumatology International|October 3, 2015
Serum urate gene associations with incident gout, measured in the Framingham Heart Study, are modified by renal disease and not by body mass indexRichard J Reynolds, Ana I Vazquez, Vinodh Srinivasasainagendra, et al.The Journal of Rheumatology|June 18, 2013
Associations of alcohol use with radiographic disease progression in African Americans with recent-onset rheumatoid arthritisMarshall L R Davis, Kaleb Michaud, Harlan Sayles, et al.Genetic Epidemiology|May 17, 2021
A novel Mendelian randomization method with binary risk factor and outcomePhilip H Allman, Inmaculada Aban, Dustin M Long, et al.Current Rheumatology Reports|July 29, 2010
Measurement of erythrocyte methotrexate polyglutamate levels: ready for clinical use in rheumatoid arthritis?Maria I Danila, Laura B Hughes, Elizabeth E Brown, et al.Arthritis Care & Research|March 26, 2016
Cost-Effectiveness of Triple Therapy Versus Etanercept Plus Methotrexate in Early Aggressive Rheumatoid ArthritisHawre Jalal, James R O'Dell, S Louis Bridges, et al.Arthritis and Rheumatism|May 21, 2013
Validation of the methotrexate-first strategy in patients with early, poor-prognosis rheumatoid arthritis: results from a two-year randomized, double-blind trialJames R O'Dell, Jeffrey R Curtis, Ted R Mikuls, et al.Arthritis Care & Research|April 24, 2014
Socioeconomic disparities in the health of african americans with rheumatoid arthritis from the southeastern United StatesAntoine R Baldassari, Rebecca J Cleveland, Beth L Jonas, et al.International Journal of Rheumatology|July 31, 2012
Markers of treatment response to methotrexate in rheumatoid arthritis: where do we stand?Karina I Halilova, Elizabeth E Brown, Sarah L Morgan, et al.Pageof 39